TC Biopharm (Holdings) Plc
TCBPY
$0.28
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -24.76% | 0.28% | -2.19% | -0.54% | -42.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -71.19% | -86.11% | -- | -- | -- |
| Total Operating Expenses | -43.45% | -14.03% | -1.26% | 0.40% | -16.62% |
| Operating Income | 43.45% | 14.03% | -66.44% | -69.24% | 6.21% |
| Income Before Tax | -404.34% | -246.36% | -148.83% | -153.01% | 765.62% |
| Income Tax Expenses | 64.47% | 71.09% | 58.90% | 58.20% | 17.00% |
| Earnings from Continuing Operations | -301.64% | -446.34% | -262.55% | -268.64% | 285.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -301.64% | -446.34% | -262.55% | -268.64% | 285.84% |
| EBIT | 43.45% | 14.03% | -66.44% | -69.24% | 6.21% |
| EBITDA | 44.31% | 13.46% | -74.38% | -77.32% | 5.50% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |